Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination decitabine and cedazuridine solid oral dosage forms

Combination decitabine and cedazuridine solid oral dosage forms

US Patent 12239653 · Granted Mar 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2′-deoxy-2′,2′-difluorotetrahydrouridines with high purity and methods of making2025
2′-deoxy-2′,2′-difluorotetrahydrouridines with high purity and methods of making2025
Combination decitabine and cedazuridine solid oral dosage forms2024
Combination decitabine and cedazuridine solid oral dosage forms2024
Combination decitabine and cedazuridine solid oral dosage forms2024
Low dose combination CDA substrate drug/cedazuridine with extended administratio2023
Low dose combination CDA substrate drug/cedazuridine with extended administratio2022
Drug compound and purification methods thereof2020
TH-302 solid forms and methods related thereto2020
Drug compound and purification methods thereof2019
Kinase inhibitor prodrug for the treatment of cancer2019
TH-302 solid forms and methods related thereto2018